You have 9 free searches left this month | for more free features.

Corneal Defect

Showing 1 - 25 of 2,506

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Corneal Edema, Corneal Defect, Anterior Chamber Inflammation Trial in Los Angeles (Dextenza 0.4Mg Ophthalmic Insert,

Not yet recruiting
  • Corneal Edema
  • +6 more
  • Dextenza 0.4Mg Ophthalmic Insert
  • +3 more
  • Los Angeles, California
    Advanced Vision Care
Dec 5, 2022

Cataract, Lens Opacities, Artificial Lens Implant Trial (Clinical Prototype BioBase (SN 07 and SN 08))

Not yet recruiting
  • Cataract
  • +5 more
  • Clinical Prototype BioBase (SN 07 and SN 08)
  • (no location specified)
Jul 12, 2022

Mesenchymal Stromal Cells, Cornea, Corneal Defect Trial (MSC Secretome Eye Drops)

Not yet recruiting
  • Mesenchymal Stromal Cells
  • +3 more
  • MSC Secretome Eye Drops
  • (no location specified)
Jan 11, 2022

Mesenchymal Stromal Cells, Cornea, Safety Trial in Chicago (Allogeneic MSC)

Recruiting
  • Mesenchymal Stromal Cells
  • +3 more
  • Allogeneic MSC
  • Chicago, Illinois
    University of Illinois, Department of Ophthalmology and Visual S
Apr 19, 2022

Persistent Corneal Epithelial Defect Trial in United States (lufepirsen, Vehicle)

Recruiting
  • Persistent Corneal Epithelial Defect
  • Pasadena, California
  • +5 more
Jul 21, 2023

Persistent Corneal Epithelial Defect Trial in United States (KPI-012, KPI-012 Vehicle)

Recruiting
  • Persistent Corneal Epithelial Defect
  • Louisville, Kentucky
  • +5 more
Feb 13, 2023

Corneal Ulcer, Persistent Corneal Epithelial Defect Trial (LV-Visio-AMTRIX)

Withdrawn
  • Corneal Ulcer
  • Persistent Corneal Epithelial Defect
  • LV-Visio-AMTRIX
  • (no location specified)
Aug 2, 2022

Persistent Corneal Epithelial Defect Trial in Mexico City (KIO-201, a Crosslinked Thiolated Carboxymethyl Hyaluronic Acid 0.75%

Recruiting
  • Persistent Corneal Epithelial Defect
  • KIO-201, a Crosslinked Thiolated Carboxymethyl Hyaluronic Acid 0.75% (CMHA-S)
  • Mexico City, Chimalpopoca 14 Colonia Obrera, Mexico
    Instituto de Oftalmología Fundación Conde de Valenciana
Jul 6, 2022

Corneal Persistent Epithelial Defect Trial in Edgewood (NEXAGON High Dose Concentration, NEXAGON Low Dose Concentration, NEXAGON

Recruiting
  • Corneal Persistent Epithelial Defect
  • Nexagon® (lufepirsen) High Dose Concentration
  • +3 more
  • Los Angeles, California
  • +4 more
Aug 25, 2022

DEXTENZA 0.4 mg inseRt Following Corneal Transplant or Cataract

Completed
  • Anterior Chamber Inflammation
  • +7 more
  • Dextenza 0.4Mg Ophthalmic Insert
  • Los Angeles, California
    Advanced Vision Care
Jul 14, 2021

Corneal Defect Trial in Shanghai (ZKY001 eye drops 0.3g:0.006mg, ZKY001 eye drops 0.3g:0.012mg, ZKY001 simulated eye drops)

Recruiting
  • Corneal Defect
  • ZKY001 eye drops 0.3g:0.006mg
  • +2 more
  • Shanghai, Shanghai, China
    Eye & Ent Hospital of Fudan University
Sep 16, 2021

Corneal Defect Trial in Beijing (Germinal peptide eye drops)

Completed
  • Corneal Defect
  • Germinal peptide eye drops
  • Beijing, China
    Xiuli Zhao
Sep 16, 2021

Persistent Epithelial Defect Trial in Monterrey (PRP plus BCL, BCL plus PFL, Eye patch plus ocular lubricant ointment)

Recruiting
  • Persistent Epithelial Defect
  • PRP plus BCL
  • +2 more
  • Monterrey, Nuevo Leon, Mexico
    Departamento de Oftalmologia, Hospital Universitario "Dr. Jose E
May 16, 2022

Corneal Epithelial Defect Trial in Riyadh (Amniotic membrane transplantation, Autologous serum/BSS 20%)

Completed
  • Corneal Epithelial Defect
  • Amniotic membrane transplantation
  • Autologous serum/BSS 20%
  • Riyadh, Saudi Arabia
    King Khaled Eye Specialist Hospital
Nov 21, 2021

Corneal Edema, Corneal Defect, Corneal Transplant Trial in Los Angeles (Dextenza 0.4Mg Ophthalmic Insert, Prednisolone Acetate

Recruiting
  • Corneal Edema
  • +5 more
  • Dextenza 0.4Mg Ophthalmic Insert
  • Prednisolone Acetate 1% Oph Susp
  • Los Angeles, California
    Advanced Vision Care
Dec 23, 2020

Results in Neurotrophic Keratopathy in Stages 2 and 3

Completed
  • Corneal Ulcer
  • +3 more
  • Topical Insulin
  • Vila Nova de Gaia, Portugal
    Centro Hospitalar Vila Nova de Gaia e Espinho
Apr 24, 2021

Persistent Corneal Epithelial Defect Trial in Amman (Platelet Lysate)

Completed
  • Persistent Corneal Epithelial Defect
  • Platelet Lysate
  • Amman, Jordan
    Cell Therapy Center
Mar 2, 2021

Persistent Corneal Epithelial Defect Trial in United States (ST266)

Completed
  • Persistent Corneal Epithelial Defect
  • ST266
  • Indianapolis, Indiana
  • +7 more
Aug 13, 2021

Persistent Corneal Epithelial Defect Trial in United States (ST266, 0.67% Sodium Chloride Ophthalmic Solution, Open-label ST266)

Terminated
  • Persistent Corneal Epithelial Defect
  • ST266
  • +2 more
  • Dothan, Alabama
  • +30 more
Oct 24, 2022

Corneal Defect Trial in Beijing (Germinal peptide eye drops)

Completed
  • Corneal Defect
  • Germinal peptide eye drops
  • Beijing, China
    Xiuli Zhao
Jan 31, 2020

Photorefractive Keratectomy Trial in Isfahan (prepared drop of medroxy progestrone acetat 1%)

Completed
  • Photorefractive Keratectomy
  • prepared drop of medroxy progestrone acetat 1%
  • Isfahan, Iran, Islamic Republic of
  • +1 more
Jul 26, 2023

Persistent Corneal Epithelial Defects, Dry Eye Trial (Autologous platelet rich plasma eye drops)

Not yet recruiting
  • Persistent Corneal Epithelial Defects
  • Dry Eye
  • Autologous platelet rich plasma eye drops
  • (no location specified)
Sep 16, 2022

Limbal Stem-cell Deficiency, Congenital Aniridia Trial in Minneapolis (transplantation of a Descemet's Membrane corneal onlay,

Not yet recruiting
  • Limbal Stem-cell Deficiency
  • Congenital Aniridia
  • transplantation of a Descemet's Membrane corneal onlay, partial LSCD
  • transplantation of a Descemet's Membrane corneal onlay, total/near-total LSCD
  • Minneapolis, Minnesota
    University of Minnesota
Jun 15, 2023

Neurotrophic Keratitis Trial in United States (rhNGF 20µg/ml, Placebo)

Completed
  • Neurotrophic Keratitis
  • rhNGF 20µg/ml
  • Placebo
  • Loma Linda, California
  • +11 more
Mar 31, 2022

Neurotrophic Keratitis Trial in Canada (Insulin, Tarsorrhaphy)

Recruiting
  • Neurotrophic Keratitis
  • Edmonton, Alberta, Canada
  • +5 more
Feb 2, 2023